Finally, we show how OptiPrime can be used to achieve highly streamlined and efficient <i>in vivo</i> correction of a pathogenic mutation in the brain of a mouse model of <i>KIF1A</i>-associated neurological disorder. The gene discussed is KIF1A; the disease is nervous system disorder.